glp 1 in india GLP-1 Drugs Boom: India’s Next Big Pharma Opportunity? Rise Of Weight-Loss Drugs India's GLP-1 Adoption Lags Despite

Plaintiffs allege the drugmakers failed to adequately warn about the severity of GI side effects while aggressively promoting these medications for both diabetes management and off-label weight loss

Some IV antioxidants can interfere with chemotherapy

Most green teas stop at taste

The ad also hit a nerve with the pharma industry, lawmakers and some industry groups

A drug that boasts 24% average weight loss in a trial might cause intolerable side effects for you, while an older drug might work perfectly

In the HOPE study it was shown that there are no beneficial effects of vitamin E administration (daily dose of vitamin E of 400 IU (268 mg) on renal complications (Lonn et al., 2005)